Finding the Small Wins as an Oncology Nurse

May 1st 2024, 7:00pm

By Don Vaughan

Oncology nurse, Meaghan Mooney, B.S.N., RN, OCN, winner of the 2024 Extraordinary Healer® award, celebrates the “small wins” with her patients.

Grateful for My Sister’s Life, Especially During a Cancer Recurrence

May 1st 2024, 5:00pm

By Kim Johnson

Through so many cancer scares, I'm trying to live in gratitude that my sister's time is not now.

How to Self-Advocate During Bladder Cancer Awareness Month

May 1st 2024, 3:00pm

By Ashley Chan

Getting second opinions is highly encouraged for patients recently diagnosed with bladder cancer because “it’s not one size fits all,” experts told CURE®.

Current First-Line Treatment Options in CLL

May 1st 2024, 2:00pm

Focusing on the first-line setting, Yuliya Linhares, MD, gives an overview of first-line treatment options for patients with chronic lymphocytic leukemia.

Goals of Treatment for Patients With CLL

May 1st 2024, 1:37pm

Josie Montegaard, MSN, AGPCNP-BC, discusses the goals of treatment for patients with chronic lymphocytic leukemia and how they may vary depending on factors such as age, risk level, and symptoms.

Hope After an Unexpected Cancer Diagnosis

May 1st 2024, 1:00pm

By Sarah Mccumba Garcia

This is the poem I wrote to help myself cope with my new diagnosis. It served as a reminder that I was resilient.

Not Giving Into the Fear Cancer Brings

April 30th 2024, 10:00pm

By Beatrice Mitchell

Accepting both my beauty and flaws helps me push away the fear cancer brings.

‘Give Yourself Grace’ After a Cancer Diagnosis, Kristen Dahlgren Says

April 30th 2024, 9:00pm

By Ashley Chan

Leaning on a community of oncology nurses, other patients and survivors can help ease the burden of receiving a cancer diagnosis, said Kristen Dahlgren.

Urine Test Decreases Cystoscopies in Patients With Bladder Cancer

April 30th 2024, 7:00pm

By Brielle Benyon

A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer.

Recognizing and Managing Stress from Cancer

April 30th 2024, 5:00pm

By Ronald Chin

I need to acknowledge and address the impact stress from multiple myeloma has on my mental and emotional wellbeing.

‘Landmark’ Findings Led to Alecensa Approval for ALK-Positive NSCLC

April 30th 2024, 3:00pm

By Alex Biese

Alecensa was shown to reduce the risk of disease recurrence or death by 76% versus chemotherapy for patients with ALK-positive non-small cell lung cancer.

Extending Healing Commitment to a Cancer Community

April 30th 2024, 1:00pm

By MEREDITH R. COOPER, M.A., CCLS, LPC

It is Meaghan’s unwavering dedication to supporting children and families during a parent’s illness, along with her willingness to take her direct patient care to practices within her professional position and her community service, that allow me to say Meaghan is truly an extraordinary healer deserving of this honor.

When My Wait and Watch Routine for Follicular Lymphoma Ended

April 29th 2024, 9:00pm

By Lynn Belzer

I reflected upon my last great trip with my husband and the moment my wait and watch approach ended for my follicular lymphoma.

FDA Approves Tivdak for Metastatic Cervical Cancer

April 29th 2024, 8:13pm

By Brielle Benyon

The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.

Herceptin Biosimilar, Hercessi, Approved by FDA in Breast, Gastric Cancers

April 29th 2024, 5:05pm

By Alex Biese

The FDA has approved Hercessi for the adjuvant treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.